Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Technology Scientific & Technical Instruments
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

Recent & Breaking News (NYSE:BIO)

Mirati Therapeutics to Take Part in the 42nd Annual Goldman Sachs Global Healthcare Conference

PR Newswire June 2, 2021

QMed Innovations Named Gold Winner of 2021 Edison Awards

PR Newswire June 2, 2021

The Chartis Group Partners with Healthcare Financial Management Association for Healthcare 2030 Research

PR Newswire June 2, 2021

CalciMedica Publishes Positive Data from Phase 2a Study of Auxora(TM) in Patients with Acute Pancreatitis and Announces First Patients Dosed in Phase 2b Study

PR Newswire June 2, 2021

Nanoform raises its mid-term business targets for 2025

PR Newswire June 2, 2021

Novartis Kisqali® reports longest median overall survival in postmenopausal HR+/HER2- metastatic breast cancer patients

PR Newswire June 2, 2021

Rabble Health Appoints Chandra Kanive to COO, Koji Sonoda to VP Business Development

PR Newswire June 2, 2021

Primordial Genetics Grants Arcturus Therapeutics Exclusive License of an RNA Polymerase for Human and Animal Therapeutics

PR Newswire June 2, 2021

D. Wade Walke, Ph.D. Joins 23andMe as Vice President of Investor Relations

PR Newswire June 2, 2021

GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement

PR Newswire June 2, 2021

NeuroOne Introduces Advisory Board for Ablation Electrode Technology that Records and Ablates Brain Tissue Linked to Seizure Activity

PR Newswire June 2, 2021

Global Cancer Technology Appoints Chief Scientific Consultant and Advisor as Company Expands to Include New Technology and Treatments for Brain Cancer, SEC filings

PR Newswire June 2, 2021

EPA Approves NEOGEN® Viroxide Super(TM) for U.S. Distribution

PR Newswire June 2, 2021

Metalytics, the Leading Provider of Metabolic Flux Analysis Services to the Life Science Sector, Introduces FirstCHOiceMFA(TM), a Powerful and Cost-effective Method for Improving CHO Productivity

PR Newswire June 2, 2021

University Products LLC Highlighted the Recent Antibiotic-Treatment Regulation by FDA in Bovine Herds as Critically Necessary; Also Indicated in New Pew Trust Research

PR Newswire June 2, 2021

Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus

PR Newswire June 2, 2021

BERG to Present Phase 1 Results of BPM 31510-IV and Identifies Therapeutic Opportunities for Recurrent GBM Patients at 2021 American Society of Clinical Oncology (ASCO) Meeting

PR Newswire June 2, 2021

The Foundation for Sarcoidosis Research announces the 2021-2023 FSR-MNK Sarcoidosis Research Fellow

PR Newswire June 2, 2021

Fastest Labs Expands into Tennessee with Newly Opened Cookeville Location

PR Newswire June 2, 2021

Portonbio announced strategic cooperation with KAEDI to accelerate the R&D and production of CAR-T drugs

PR Newswire June 2, 2021